Myhep LVIR Tablet 90 mg + 400 mg

Myhep LVIR Tablet 90 mg + 400 mg is a prescription antiviral medicine that contains ledipasvir 90 mg and sofosbuvir 400 mg in each tablet. It belongs to the direct-acting antiviral class and is used to treat chronic hepatitis C infection in appropriate patients. This tablet form is designed for once-daily treatment plans chosen by a doctor based on the hepatitis C genotype, liver condition, and other medicines you take. Myhep LVIR Tablet 90 mg + 400 mg is not a cure for every type of hepatitis or liver disease, so it should only be used exactly as prescribed.

How it works: Ledipasvir blocks a hepatitis C protein called NS5A, which the virus needs to make new copies of itself. Sofosbuvir blocks another viral enzyme called NS5B, helping stop the virus from multiplying, and the tablet form delivers both medicines together in one daily dose.

Myhep LVIR Tablet 90 mg + 400 mg is the full-strength tablet that combines ledipasvir 90 mg with sofosbuvir 400 mg in one dose. Because there are no sibling strengths or forms listed for this brand, this tablet represents the standard fixed-dose product rather than a lower-step option. A doctor may choose Myhep LVIR Tablet 90 mg + 400 mg when this exact fixed-dose combination is appropriate for the patient’s treatment plan.

• Treatment of chronic hepatitis C infection
• Part of a direct-acting antiviral regimen
• Used in selected patients with or without compensated liver disease
• May be used with other medicines in some treatment plans
• Helps reduce hepatitis C virus in the blood

• Take Myhep LVIR Tablet 90 mg + 400 mg exactly as prescribed by your doctor.
• Swallow the tablet whole with water; do not crush, chew, or split it unless your prescriber specifically tells you to.
• Take it at the same time every day to help keep a steady amount of medicine in your body.
• You may take it with or without food unless your doctor gives different instructions.
• If you miss a dose, take it as soon as you remember the same day; do not double up unless your clinician tells you to.
• Do not stop taking Myhep LVIR Tablet 90 mg + 400 mg early, even if you feel better, because the infection may not be fully treated.

Each Myhep LVIR Tablet provides 90 mg of ledipasvir and 400 mg of sofosbuvir per tablet. It is commonly taken once daily, but the exact schedule and treatment duration are decided by the doctor based on the hepatitis C type, liver status, and other medicines. Do not take more than the prescribed number of tablets in 24 hours.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Ledipasvir + Sofosbuvir may include:

• Fatigue
• Headache
• Nausea
• Diarrhea
• Trouble sleeping
• Weakness
• Mild dizziness

• Do not use this tablet without a doctor’s prescription and hepatitis C evaluation.
• Tell your doctor if you have liver disease, kidney disease, a history of hepatitis B, or a heart rhythm disorder.
• This medicine can interact with drugs for heart rhythm control, seizure control, HIV, and acid-reducing therapy.
• Alcohol can worsen liver injury, so ask your clinician whether to avoid it during treatment.
• If you have ever had hepatitis B, you may need monitoring because hepatitis B can flare during or after treatment.
• Do not take extra tablets because this is a full-strength fixed-dose product.
• Tell your doctor if you become pregnant, plan to become pregnant, or are breastfeeding so risks and benefits can be reviewed.

• Amiodarone
• Rifampin or rifabutin
• Certain antacids, H2 blockers, or proton pump inhibitors
• Carbamazepine, phenytoin, or phenobarbital
• St. John’s wort

Store Myhep LVIR Tablet 90 mg + 400 mg in the original strip or box at room temperature, away from excess heat, moisture, and direct light.